S&P 500   4,205.52
DOW   33,042.78
QQQ   349.98
The "How" and "Why" of Investing in 5G Stocks
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
Palantir: The "Sleeper" Play on the AI Revolution
The single greatest medical breakthrough of all time? (Ad)
Keep An Eye On These 5 Small-Cap AI Companies
AI Chip Stock Showdown: The Biggest Winners and Losers
Your Ultimate Investment Research Platform (Ad)
Workday: Another AI Winner Melting-Up 
Taiwan Semiconductor Well Positioned for the AI Rush
S&P 500   4,205.52
DOW   33,042.78
QQQ   349.98
The "How" and "Why" of Investing in 5G Stocks
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
Palantir: The "Sleeper" Play on the AI Revolution
The single greatest medical breakthrough of all time? (Ad)
Keep An Eye On These 5 Small-Cap AI Companies
AI Chip Stock Showdown: The Biggest Winners and Losers
Your Ultimate Investment Research Platform (Ad)
Workday: Another AI Winner Melting-Up 
Taiwan Semiconductor Well Positioned for the AI Rush
S&P 500   4,205.52
DOW   33,042.78
QQQ   349.98
The "How" and "Why" of Investing in 5G Stocks
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
Palantir: The "Sleeper" Play on the AI Revolution
The single greatest medical breakthrough of all time? (Ad)
Keep An Eye On These 5 Small-Cap AI Companies
AI Chip Stock Showdown: The Biggest Winners and Losers
Your Ultimate Investment Research Platform (Ad)
Workday: Another AI Winner Melting-Up 
Taiwan Semiconductor Well Positioned for the AI Rush
S&P 500   4,205.52
DOW   33,042.78
QQQ   349.98
The "How" and "Why" of Investing in 5G Stocks
Why 2023 Could Kick Off a "Cash Frenzy" in Stocks (Ad)
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
Palantir: The "Sleeper" Play on the AI Revolution
The single greatest medical breakthrough of all time? (Ad)
Keep An Eye On These 5 Small-Cap AI Companies
AI Chip Stock Showdown: The Biggest Winners and Losers
Your Ultimate Investment Research Platform (Ad)
Workday: Another AI Winner Melting-Up 
Taiwan Semiconductor Well Positioned for the AI Rush
NYSE:IVC

Invacare (IVC) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
N/A
50-Day Range
$0.35
▼
$0.74
52-Week Range
N/A
Volume
33,301 shs
Average Volume
240,305 shs
Market Capitalization
$20.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00
ProfileAnalyst RatingsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Invacare MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
∞ Upside
$2.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
-0.81
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.76) to ($1.59) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.46 out of 5 stars

Medical Sector

943rd out of 1,009 stocks

Surgical Appliances & Supplies Industry

20th out of 20 stocks

See Top Rated MarketRank™ Stocks Here

IVC stock logo

About Invacare (NYSE:IVC) Stock

Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.

Receive IVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invacare and its competitors with MarketBeat's FREE daily newsletter.

IVC Stock News Headlines

May 15, 2023 | finance.yahoo.com
Invacare Reports Results for First Quarter 2023
May 10, 2023 | marketwatch.com
Invacare Holdings Corporation Completes Financial Restructuring and is Well Positioned to Drive Forward in its Transformation
May 31, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
April 17, 2023 | finance.yahoo.com
INVO Reports Fourth Quarter and Full Year 2022 Financial Results
February 1, 2023 | finance.yahoo.com
Invacare files for bankruptcy
February 1, 2023 | finance.yahoo.com
Invacare Files For Chapter 11, But Expects To Continue Focusing On Home-Care Products
February 1, 2023 | finance.yahoo.com
Invacare Corporation Takes Action to Strengthen Its Financial Position and Drive Long-Term Growth Through Voluntary Prearranged Chapter 11 Cases That Do Not Include Its International Operations
February 1, 2023 | finance.yahoo.com
Invacare files for bankruptcy, but expects to keep making and delivering home-care products
May 31, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
February 1, 2023 | investorplace.com
Why Is Invacare (IVC) Stock Down 20% Today?
December 27, 2022 | finance.yahoo.com
Invacare draws more on term loan from hedge fund manager
December 27, 2022 | finance.yahoo.com
Invacare Corporation Announces Additional Draw of Term Loans
November 23, 2022 | 247wallst.com
Azurite Trims Invacare Stake after Inadvertently Passing 10% Ownership Trigger
November 22, 2022 | finance.yahoo.com
Invacare picks Geoff Purtill as permanent president, CEO
November 21, 2022 | finance.yahoo.com
Invacare Appoints Geoff Purtill President and Chief Executive Officer
November 14, 2022 | finance.yahoo.com
The Consensus EPS Estimates For Invacare Corporation (NYSE:IVC) Just Fell Dramatically
November 10, 2022 | finance.yahoo.com
Invacare Third Quarter 2022 Earnings: Misses Expectations
November 7, 2022 | finance.yahoo.com
Invacare Reports Results for Third Quarter 2022
October 20, 2022 | businesswire.com
Invacare Corporation to Host Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results - Business Wire
October 20, 2022 | finance.yahoo.com
Invacare Corporation to Host Conference Call and Webcast to Discuss Third Quarter 2022 Financial Results
October 15, 2022 | globenewswire.com
Wheelchairs & Mobility Aids Market Research Report by Product, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 - GlobeNewswire
October 14, 2022 | finance.yahoo.com
Wheelchairs & Mobility Aids Market Research Report by Product, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 - Yahoo Finance
October 12, 2022 | finance.yahoo.com
[Latest] Global Electric Wheelchair Market Size/Share Worth 7.14 Billion by 2030 at a 7% CAGR: Custom Market Insights (Outlook, Report, Trends, Forecast, Trends, Segmentation) - Yahoo Finance
October 11, 2022 | benzinga.com
Wheelchair Market Size to Grow by USD 1320.66 Bn, Healthcare Equipment Market Categorized as Parent Marke - Benzinga
October 10, 2022 | prnewswire.com
Wheelchair Market Size to Grow by USD 1320.66 Bn, Healthcare Equipment Market Categorized as Parent Market - Technavio - PR Newswire
October 7, 2022 | globenewswire.com
Global Home Rehabilitation Products Market to Reach $43.6 Billion by 2031: Allied Market Research - GlobeNewswire
September 29, 2022 | seekingalpha.com
Invacare receives non-compliance letter from NYSE - Seeking Alpha
See More Headlines

Receive IVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invacare and its competitors with MarketBeat's FREE daily newsletter.

IVC Company Calendar

Last Earnings
10/27/2021
Today
5/31/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NYSE:IVC
CUSIP
46120310
CIK
742112
Web
www.invacare.com
Phone
(440) 329-6000
Fax
877-619-7996
Employees
3,000
Year Founded
1885

Price Target and Rating

Average Stock Price Forecast
$2.00
High Stock Price Forecast
$2.00
Low Stock Price Forecast
$2.00
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($2.18)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-45,560,000.00
Net Margins
-9.99%
Pretax Margin
-9.38%
Return on Equity
-37.76%
Return on Assets
-7.18%

Debt

Debt-to-Equity Ratio
4.82
Current Ratio
1.32
Quick Ratio
0.78

Sales & Book Value

Annual Sales
$872.46 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
0.77
Book Value
$5.54 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
37,760,000
Free Float
35,153,000
Market Cap
$20.01 million
Optionable
Optionable
Beta
0.38

Social Links


Key Executives

  • Geoffrey P. Purtill
    President, Chief Executive Officer & Director
  • Kathleen Patricia Leneghan
    Senior VP, Chief Financial & Accounting Officer
  • Angie Goodwin
    SVP, Chief Technology & Information Officer
  • Joost Beltman
    Senior VP & General Manager-North America
  • Anthony C. LaPlacaAnthony C. LaPlaca
    Secretary, Chief Administrative Officer & SVP

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













IVC Stock - Frequently Asked Questions

What is Invacare's stock price forecast for 2023?

0 brokerages have issued twelve-month price objectives for Invacare's shares. Their IVC share price forecasts range from $2.00 to $2.00. On average, they anticipate the company's share price to reach $2.00 in the next year.
View analysts price targets for IVC or view top-rated stocks among Wall Street analysts.

How were Invacare's earnings last quarter?

Invacare Co. (NYSE:IVC) posted its earnings results on Wednesday, October, 27th. The health services provider reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.08. The health services provider earned $224.20 million during the quarter, compared to analyst estimates of $222.27 million. Invacare had a negative net margin of 9.99% and a negative trailing twelve-month return on equity of 37.76%. During the same quarter in the previous year, the company earned ($0.10) earnings per share.

What is Matthew E. Monaghan's approval rating as Invacare's CEO?

51 employees have rated Invacare Chief Executive Officer Matthew E. Monaghan on Glassdoor.com. Matthew E. Monaghan has an approval rating of 37% among the company's employees. This puts Matthew E. Monaghan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Invacare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invacare investors own include Pfizer (PFE), Intel (INTC), CrowdStrike (CRWD), Micron Technology (MU), OPKO Health (OPK), ONEOK (OKE), Corbus Pharmaceuticals (CRBP), Exelixis (EXEL), Five Prime Therapeutics (FPRX) and Inovio Pharmaceuticals (INO).

What is Invacare's stock symbol?

Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC."

Who are Invacare's major shareholders?

Invacare's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Simplex Trading LLC (0.00%) and Belvedere Trading LLC (0.00%). Insiders that own company stock include Anthony Laplaca, Baiju R Shah, Kathleen P Leneghan, Matthew E Monaghan and Steven H Rosen.
View institutional ownership trends.

How much money does Invacare make?

Invacare (NYSE:IVC) has a market capitalization of $0.00 and generates $872.46 million in revenue each year. The health services provider earns $-45,560,000.00 in net income (profit) each year or ($2.18) on an earnings per share basis.

How many employees does Invacare have?

The company employs 3,000 workers across the globe.

How can I contact Invacare?

Invacare's mailing address is ONE INVACARE WAY, ELYRIA OH, 44036. The official website for the company is www.invacare.com. The health services provider can be reached via phone at (440) 329-6000, via email at loislee@invacare.com, or via fax at 877-619-7996.

This page (NYSE:IVC) was last updated on 5/31/2023 by MarketBeat.com Staff

My Account -